{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T05:56:55Z","timestamp":1790143015553,"version":"4.0.1"},"reference-count":20,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2010,7]]},"DOI":"10.1097\/md.0b013e3181e763be","type":"journal-article","created":{"date-parts":[[2010,7,8]],"date-time":"2010-07-08T04:21:32Z","timestamp":1278562892000},"page":"211-216","source":"Crossref","is-referenced-by-count":16,"title":["Changing Pattern of Presentation in Monoclonal Gammopathy of Undetermined Significance"],"prefix":"10.1097","volume":"89","author":[{"given":"Marzia","family":"Varettoni","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Corso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Cocito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Mangiacavalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Pascutto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Zappasodi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianmatteo","family":"Pica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Lazzarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-3-20210309","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1111\/j.0954-6820.1966.tb05453.x","article-title":"Frequency of pathological proteins (M-components) in 6,995 sera from an adult population.","volume":"179","author":"Axelsson","year":"1966","journal-title":"Acta Med Scand"},{"key":"R2-3-20210309","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1182\/blood.V87.3.912.bloodjournal873912","article-title":"Role of different hematologic variables in defining the risk of malignant transformation in monoclonal gammopathy.","volume":"87","author":"Baldini","year":"1996","journal-title":"Blood"},{"key":"R3-3-20210309","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/j.1365-2141.1992.tb08245.x","article-title":"Malignant transformation and life expectancy in MGUS.","volume":"81","author":"Blade","year":"1992","journal-title":"Br J Haematol"},{"key":"R4-3-20210309","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1038\/leu.2008.203","article-title":"Pathogenesis and progression of monoclonal gammopathy of undetermined significance.","volume":"22","author":"Blade","year":"2008","journal-title":"Leukemia"},{"key":"R5-3-20210309","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1200\/JCO.2002.20.6.1625","article-title":"Prognostic factors for malignant transformation in monoclonal gammopathy of undetermined significance and smouldering multiple myeloma.","volume":"20","author":"Cesana","year":"2002","journal-title":"J Clin Oncol"},{"key":"R6-3-20210309","doi-asserted-by":"crossref","first-page":"2355","DOI":"10.1182\/blood-2009-06-229120","article-title":"A monoclonal gammopathy in search of clinical significance: 57 years later.","volume":"114","author":"Go","year":"2009","journal-title":"Blood"},{"key":"R7-3-20210309","first-page":"1172","article-title":"The impact of M-component type and immunoglobulin concentration on the risk of malignant transformation in patients with monoclonal gammopathy of undetermined significance.","volume":"86","author":"Gregersen","year":"2001","journal-title":"Haematologica"},{"key":"R8-3-20210309","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1046\/j.1365-2141.2001.02533.x","article-title":"Mortality and causes of death in patients with monoclonal gammopathy of undetermined significance.","volume":"112","author":"Gregersen","year":"2001","journal-title":"Br J Haematol"},{"key":"R9-3-20210309","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1046\/j.1365-2141.2003.04355.x","article-title":"Criteria for the classification of monoclonal gammopathies, multiple myeloma and related disorders: a report of the International Myeloma Working Group.","volume":"121","year":"2003","journal-title":"Br J Haematol"},{"key":"R10-3-20210309","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.3324\/haematol.2009.010066","article-title":"Patterns of survival and causes of death following a diagnosis of monoclonal gammopathy of undetermined significance (MGUS) a population-based study.","volume":"94","author":"Kristinsson","year":"2009","journal-title":"Haematologica"},{"key":"R11-3-20210309","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A long-term study of prognosis in monoclonal gammopathy of undetermined significance.","volume":"346","author":"Kyle","year":"2002","journal-title":"N Engl J Med"},{"key":"R12-3-20210309","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance.","volume":"354","author":"Kyle","year":"2006","journal-title":"N Engl J Med"},{"key":"R13-3-20210309","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1053\/sonc.2003.50068","article-title":"Predictive variables for malignant transformation in 452 patients with asymptomatic IgM monoclonal gammopathy.","volume":"30","author":"Morra","year":"2003","journal-title":"Semin Oncol"},{"key":"R14-3-20210309","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1093\/clinchem\/28.4.707","article-title":"Incidence of gamma-globulin banding in a healthy population by high-resolution electrophoresis.","volume":"28","author":"Papadopoulos","year":"1982","journal-title":"Clin Chem"},{"key":"R15-3-20210309","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2005-03-1038","article-title":"Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance.","volume":"106","author":"Rajkumar","year":"2005","journal-title":"Blood"},{"key":"R16-3-20210309","doi-asserted-by":"crossref","first-page":"428","DOI":"10.4065\/82.4.428","article-title":"Monoclonal gammopathy of undetermined significance: predictors of malignant transformation and recognition of an evolving type characterized by a progressive increase in M protein size.","volume":"82","author":"Rosinol","year":"2007","journal-title":"Mayo Clin Proc"},{"key":"R17-3-20210309","doi-asserted-by":"crossref","first-page":"4439","DOI":"10.1158\/1078-0432.CCR-08-3150","article-title":"Proposal and validation of prognostic scoring systems for IgG and IgA monoclonal gammopathies of undetermined significance.","volume":"15","author":"Rossi","year":"2009","journal-title":"Clin Cancer Res"},{"key":"R18-3-20210309","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2141.2008.07423.x","article-title":"Long-term follow-up of a population based cohort with monoclonal proteinaemia.","volume":"144","author":"Schaar","year":"2009","journal-title":"Br J Haematol"},{"key":"R19-3-20210309","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1111\/j.1365-2141.1986.tb02236.x","article-title":"The incidence of monoclonal gammopathy in a population over 45 years old determined by isoelectric focusing.","volume":"64","author":"Sinclair","year":"1986","journal-title":"Br J Haematol"},{"key":"R20-3-20210309","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-2141.1995.tb05256.x","article-title":"Malignant transformation of monoclonal gammopathy of undetermined significance among out-patients of a community hospital in southeastern Netherlands.","volume":"91","author":"Van de Poel","year":"1995","journal-title":"Br J Haematol"}],"container-title":["Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MD.0b013e3181e763be","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:28:29Z","timestamp":1786040909000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00005792-201007000-00003"}},"subtitle":["A Single-Center Experience With 1400 Patients"],"short-title":[],"issued":{"date-parts":[[2010,7]]},"references-count":20,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2010]]}},"URL":"https:\/\/doi.org\/10.1097\/md.0b013e3181e763be","relation":{},"ISSN":["0025-7974"],"issn-type":[{"value":"0025-7974","type":"print"}],"subject":[],"published":{"date-parts":[[2010,7]]}}}